Security key
89854M101
TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)
CUSIP: 89854M101
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Voting Common Stock, $0.0001 par value per share
- Total 13F shares
- 41,438,662
- Total 13F value
- $242,461,718
- Share change
- +7,144,001
- SEC-reported price per share
- $5.85
- Number of holders
- 78
- Value change
- +$40,505,361
- Number of buys
- 48
- Number of sells
- 29
- Shares outstanding
- 55,838,719
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
78
Top holders
10
TCRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
TScan Therapeutics, Inc. SEC filings
TScan Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89854M101
Recent filing periods:
Ownership snapshot
Top reported holders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lynx1 Capital Management LP
Disclosed value leader
Lynx1 Capital Management LP
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 9.4%
Showing 1-6 of 15 holder rows.
Quick read
Lynx1 Capital Management LP leads the comparable SEC ownership view at 9.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lynx1 Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Lynx1 Capital Management LP
9.4%
EcoR1 Capital, LLC
9%
ADAGE CAPITAL PARTNERS GP, L.L.C.
7%
BVF INC/IL
5.4%
BAKER BROS. ADVISORS LP
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
13F
Company
|
9.4%
|
$41,483,324
5,224,600 shares
|
— | 31 Mar 2024 |
| EcoR1 Capital, LLC |
13F
3/4/5
Company · 10%+ Owner
|
9%
|
$39,700,000
5,000,000 shares
|
— | 31 Mar 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
7%
|
$30,966,000
3,900,000 shares
|
— | 31 Mar 2024 |
| BVF INC/IL |
13F
Company
|
5.4%
|
$23,736,424
2,989,474 shares
|
— | 31 Mar 2024 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
5%
|
$22,111,248
2,784,792 shares
|
— | 31 Mar 2024 |
| Propel Bio Management, LLC |
13F
Company
|
3.7%
|
$16,571,884
2,087,139 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
78
Shares
41,438,662
Rows available
78
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
65
Q2 2024 holders
78
Holder diff
13
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend